Prostate Cancer Human Prostate Tissue Genomic DNA, Donor 192 (CAT#: DBFF-0624-HY3009)

Datasheet

Overview

Prostate cancer is a malignant tumor that occurs in the prostate tissue and is characterized by uncontrolled growth and proliferation of tumor cells, invasion of surrounding tissues and even metastasis to other parts. Prostate Cancer Human Prostate Tissue Genomic DNA, Donor 192 is a highly pure intact high molecular size DNA. It is extracted from prostate tissue of prostate cancer human donor and treated with DNase-free RNase to remove contaminant RNA. Its purity and intactness make it an ideal choice for researchers seeking reliable and accurate data in their genetic research.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Male

Age At Sampling

62 yrs

Race

White or Caucasian

Medical Diagnosis

Adenocarcinoma of prostate

Product Description

Species

Human

Tissue Name

Prostate

Sample Diagnosis Category

Prostate Cancer

28S/18S Ratio

1.99

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Southern blot analysis, polymerase chain reaction amplification, genomic DNA methylation, single nucleotide polymorphism analysis, profiling studies in gene expression, and DNA library construction.

Product Properties

Normal Ratio

60%

Lesional Ratio

Tumor Ratio

40%

Hypocellular/Acellular Tumor Stroma Ratio

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

H&E Staining Pathological Verification

Non tumor structures: 40% epithelium, 60% fibromuscular stroma

Histopathological Grade

Gleason Score: 3+3=6/10

Tumor Stage

Primary Tumor (T)

T2c

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use